ENANTA PHARMACEUTICALS, INC Common Stock, Value, Issued
ENANTA PHARMACEUTICALS, INC (ENTA) had Common Stock, Value, Issued of $291.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-12
- 2026-06-30: Common Stock, Value, Issued $291.00K.
- 2026-03-31: Common Stock, Value, Issued $291.00K.
- 2025-12-31: Common Stock, Value, Issued $290.00K.
- 2025-09-30: Common Stock, Value, Issued $214.00K.
| Period end | Common Stock, Value, Issued |
|---|---|
| 2026-06-30 | $291.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $291.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $290.00K 10-Q · filed 2026-02-11 |
| 2025-09-30 | $214.00K 10-Q · filed 2026-08-12 |
| 2025-06-30 | $214.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $214.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $213.00K 10-Q · filed 2025-02-12 |
| 2024-09-30 | $212.00K 10-K · filed 2025-11-19 |
| 2024-06-30 | $212.00K 10-Q · filed 2024-08-07 |
| 2024-03-31 | $212.00K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $212.00K 10-Q · filed 2024-02-08 |
| 2023-09-30 | $211.00K 10-K · filed 2024-11-27 |
| 2023-06-30 | $210.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $210.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $209.00K 10-Q · filed 2023-02-08 |
| 2022-09-30 | $208.00K 10-K · filed 2023-11-22 |
| 2022-06-30 | $207.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $206.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $205.00K 10-Q · filed 2022-02-10 |
| 2021-09-30 | $202.00K 10-K · filed 2022-11-23 |
| 2021-06-30 | $202.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $202.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $201.00K 10-Q · filed 2021-02-09 |
| 2020-09-30 | $201.00K 10-K · filed 2021-11-24 |
| 2020-06-30 | $201.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $200.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $198.00K 10-Q · filed 2020-02-10 |
| 2019-09-30 | $197.00K 10-K · filed 2020-11-25 |
| 2019-06-30 | $197.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $197.00K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $194.00K 10-Q · filed 2019-02-08 |
| 2018-09-30 | $194.00K 10-K · filed 2019-11-27 |
| 2018-06-30 | $194.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $193.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $191.00K 10-Q · filed 2018-02-09 |
| 2017-09-30 | $191.00K 10-K · filed 2018-11-29 |
| 2017-06-30 | $191.00K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $191.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $190.00K 10-Q · filed 2017-02-09 |
| 2016-09-30 | $190.00K 10-K · filed 2017-12-11 |
| 2016-06-30 | $190.00K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $190.00K 10-Q · filed 2016-05-10 |
| 2015-12-31 | $188.00K 10-Q · filed 2016-02-09 |
| 2015-09-30 | $187.00K 10-K · filed 2016-12-09 |
| 2015-06-30 | $189.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $189.00K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $188.00K 10-Q · filed 2015-02-06 |
| 2014-09-30 | $188.00K 10-K · filed 2015-12-11 |
| 2014-06-30 | $188.00K 10-Q · filed 2014-08-12 |
| 2014-03-31 | $187.00K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $182.00K 10-Q · filed 2014-02-13 |
| 2013-09-30 | $181.00K 10-K · filed 2014-12-11 |
| 2013-06-30 | $180.00K 10-Q · filed 2013-08-12 |
| 2013-03-31 | $180.00K 10-Q · filed 2013-05-15 |
| 2012-09-30 | $13.00K 10-K · filed 2013-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |